RU2014140795A - Активированная иммуностимулирующая клеточная композиция, используемая для лечения инфекционных заболеваний - Google Patents
Активированная иммуностимулирующая клеточная композиция, используемая для лечения инфекционных заболеваний Download PDFInfo
- Publication number
- RU2014140795A RU2014140795A RU2014140795A RU2014140795A RU2014140795A RU 2014140795 A RU2014140795 A RU 2014140795A RU 2014140795 A RU2014140795 A RU 2014140795A RU 2014140795 A RU2014140795 A RU 2014140795A RU 2014140795 A RU2014140795 A RU 2014140795A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- treating
- dendritic cells
- infection
- viral infection
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 28
- 208000035473 Communicable disease Diseases 0.000 title 1
- 230000036039 immunity Effects 0.000 title 1
- 210000000265 leukocyte Anatomy 0.000 claims abstract 30
- 210000004443 dendritic cell Anatomy 0.000 claims abstract 22
- 208000036142 Viral infection Diseases 0.000 claims abstract 20
- 230000009385 viral infection Effects 0.000 claims abstract 20
- 230000035800 maturation Effects 0.000 claims abstract 5
- 230000000284 resting effect Effects 0.000 claims abstract 5
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims abstract 3
- 230000035939 shock Effects 0.000 claims abstract 3
- 230000007704 transition Effects 0.000 claims abstract 3
- 208000015181 infectious disease Diseases 0.000 claims 12
- 230000002458 infectious effect Effects 0.000 claims 4
- 230000003319 supportive effect Effects 0.000 claims 3
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 2
- 241000725303 Human immunodeficiency virus Species 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 241001631646 Papillomaviridae Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 208000028172 protozoa infectious disease Diseases 0.000 claims 1
- 230000004041 dendritic cell maturation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/46—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261611180P | 2012-03-15 | 2012-03-15 | |
| US61/611,180 | 2012-03-15 | ||
| PCT/IB2013/000935 WO2013136191A1 (en) | 2012-03-15 | 2013-03-13 | Activated immunostimulatory cell composition for therapy of infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014140795A true RU2014140795A (ru) | 2016-05-10 |
Family
ID=48483110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014140795A RU2014140795A (ru) | 2012-03-15 | 2013-03-13 | Активированная иммуностимулирующая клеточная композиция, используемая для лечения инфекционных заболеваний |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20150071892A1 (enExample) |
| EP (1) | EP2825182A1 (enExample) |
| JP (1) | JP2015509974A (enExample) |
| CA (1) | CA2864838A1 (enExample) |
| IN (1) | IN2014DN08407A (enExample) |
| MX (1) | MX2014010893A (enExample) |
| RU (1) | RU2014140795A (enExample) |
| WO (1) | WO2013136191A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013005610A2 (pt) | 2010-09-09 | 2019-09-24 | Macrocure Ltd | sobrenadante condicionado de leucócito, alcs, método para o tratamento de uma ferida, método para a inibição do surgimento de infecção em uma ferida, método, sobrenadante e produto |
| CA3037882A1 (en) * | 2016-09-23 | 2018-03-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same |
| EP3692997A4 (en) * | 2017-10-03 | 2021-09-29 | Tokyo Metropolitan Institute of Medical Science | FLU MEDICATION |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7713739B1 (en) | 2000-11-17 | 2010-05-11 | Novartis Vaccines And Diagnostics, Inc. | Microparticle-based transfection and activation of dendritic cells |
| KR101131727B1 (ko) | 2004-06-11 | 2012-03-28 | 가톨릭대학교 산학협력단 | ＣＥＡ-특이적인 세포독성 Ｔ세포를 생성하는 재조합 아데노바이러스 ＡｄＶＣＥＡ로 트랜스덕션된 수지상세포, 이를 포함하는 백신 및 약제학적 조성물 |
| EP1748067A1 (en) | 2005-07-29 | 2007-01-31 | Institut Pasteur | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
| CN102438635B (zh) | 2009-03-05 | 2014-09-17 | 马克罗柯尔有限公司 | 活化的白细胞组合物 |
-
2013
- 2013-03-13 MX MX2014010893A patent/MX2014010893A/es unknown
- 2013-03-13 CA CA2864838A patent/CA2864838A1/en not_active Abandoned
- 2013-03-13 US US14/385,126 patent/US20150071892A1/en not_active Abandoned
- 2013-03-13 IN IN8407DEN2014 patent/IN2014DN08407A/en unknown
- 2013-03-13 WO PCT/IB2013/000935 patent/WO2013136191A1/en not_active Ceased
- 2013-03-13 EP EP13724621.1A patent/EP2825182A1/en not_active Withdrawn
- 2013-03-13 JP JP2014561542A patent/JP2015509974A/ja active Pending
- 2013-03-13 RU RU2014140795A patent/RU2014140795A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2825182A1 (en) | 2015-01-21 |
| WO2013136191A1 (en) | 2013-09-19 |
| US20150071892A1 (en) | 2015-03-12 |
| CA2864838A1 (en) | 2013-09-19 |
| MX2014010893A (es) | 2015-06-23 |
| JP2015509974A (ja) | 2015-04-02 |
| IN2014DN08407A (enExample) | 2015-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010111747A (ru) | Способ получения противовирусных вакцин | |
| JP2019520061A5 (enExample) | ||
| RU2012146775A (ru) | Вирусная частица, высвобождающаяся после инфицирования клеток млекопитающих цитомегаловирусом человека (hcmv), содержащая слитый белок, и ее применение | |
| RU2015114543A (ru) | Способы лечения гепатита с | |
| HK1254397A1 (zh) | 通過t細胞療法治療cmv視網膜炎的方法 | |
| MX2022001967A (es) | Composiciones de células t específicas para virus de terceros y métodos para prepararlas y usarlas en profilaxis antiviral. | |
| RU2014140795A (ru) | Активированная иммуностимулирующая клеточная композиция, используемая для лечения инфекционных заболеваний | |
| WO2011146612A3 (en) | Latent human immunodeficiency virus reactivation | |
| WO2020252441A3 (en) | Activated lymphocytic cells and methods of using the same to treat cancer and infectious conditions | |
| PT1002055E (pt) | Recuperacao de virus a partir de culturas celulares utilizando uma solucao salina hipertonica | |
| Oswald et al. | E3 ubiquitin ligases in gammaherpesviruses and HIV: A review of virus adaptation and exploitation | |
| CN115040517A (zh) | 石蒜碱在防治svcv感染中的应用 | |
| RU2014117294A (ru) | 4,6-ди(3,12-диаза-6,9-диазониадиспиро[5.2.5.2]гексадекан-1-ил)-2-метил-5-нитропиримидин тетрахлорид дигидрохлорид гексагидрат для лечения герпетической инфекции, фармацевтическая композиция для местного применения | |
| RU2522868C1 (ru) | Способ изготовления вакцины против ящура | |
| CN102397538A (zh) | 亚甲蓝光化学病毒灭活方法制备的病毒疫苗的应用 | |
| CN114869883B (zh) | Esi-09在防治svcv感染中的应用 | |
| Sneller et al. | HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence? | |
| RU2502522C1 (ru) | Способ получения вакцины против вирусной диареи крупного рогатого скота | |
| CN103585155B (zh) | Trigolutesins A在治疗肾综合征出血热药物中的应用 | |
| CN103463002B (zh) | Racemosins A在制备治疗肾综合征出血热药物中的应用 | |
| CN103520171B (zh) | Kadcoccitones A在制备治疗肾综合征出血热药物中的应用 | |
| RU2012134084A (ru) | Вакцина против ящура типа а инактивированная сорбированная | |
| CN103751180B (zh) | 一种化合物在治疗肾综合征出血热药物中的应用 | |
| CN104056268A (zh) | 一种具有抗人乳头瘤病毒及子宫内膜炎症的新型制剂 | |
| Dunnick et al. | The future of interferon as an antiviral drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20160314 |